Weight Loss Drugs and Stomach Paralysis Lawsuits
Weight loss drug lawsuits allege that the medications, also used to treat diabetes, may lead to the development of severe gastroparesis/stomach paralysis, a condition characterized by food moving too slowly (or not at all) from the stomach to the small intestine. These legal actions contend that the manufacturers of Ozempic, along with along with Mounjaro, Rybelsus, Saxenda, Trulicity, Victoza, and Wegovy, failed to adequately inform the public about this potential risk. As a result, plaintiffs are pursuing compensation for the injuries they have sustained. If you experienced serious injury taking diabetes or weight loss drug injections, you may be eligible for compensation. Call the pharmaceutical lawyers at Thornton Law Firm at 888-491-9726 to discuss your legal rights.
Drugs Alleged to Cause Stomach Paralysis/Gastroparesis
– Ozempic (semaglutide) is a pharmaceutical drug prescribed to help treat type 2 diabetes. Classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, Ozempic operates by promoting insulin production and lowering glucose production in the liver, helping reduce blood sugar levels. Ozempic, manufactured by Novo Nordisk, is available as an injection.
– Mounjaro (tripeptide) is also a GLP-1 receptor agonist prescribed to treat diabetes. The injectable medicine is produced by Eli Lilly. It is not currently approved for weight loss.
– Rybelsus (semaglutide) is the same medication as Ozempic, but available in pill form. It is also manufactured by Novo Nordisk. It is only approved to treat Type 2 diabetes.
– Saxenda (liraglutide) is a weight loss medication for people with a BMI of 30 or higher or for people with a BMI of 27 and higher who also have a metabolic health condition. Saxenda is not approved to treat Type 2 diabetes.
– Trulicity (dulaglutide) is a diabetes drug that belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RA). This drug mimics the action of a glucagon-like peptide-1 (GLP-1) and helps regulate blood sugar levels. Trulicity is not approved for weight loss.
– Victoza (liraglutide) is approved for the treatment of type 2 diabetes. It is not approved for weight loss.
– Wegovy (semaglutide) is the same active compound as Ozempic, but in a much higher dose. It is approved for both weight loss and Type 2 diabetes.
The lawsuits allege that the manufacturers of these drugs generated billions in revenue by promoting them as diabetes and weight loss solutions while failing to disclose to consumers what they knew about the drugs’ side effects.
Injuries Associated With Weight Loss and Diabetes Drug Injections
The latest weight loss and diabetes drug stomach paralysis lawsuits have been initiated by individuals who took the drugs and subsequently experienced gastroparesis, a serious condition characterized by the delayed transit of food from the stomach to the small intestine. In certain instances, food movement through the intestine may come to a complete halt. These drugs have been linked to acute gallbladder disease; biliary diseases; gallstones (cholelithiasis); and inflammation of the gallbladder (cholecystitis).
The symptoms of gastroparesis may include:
– nausea
– vomiting
– abdominal bloating
– abdominal discomfort
– severe dehydration
– acid reflux
– malnutrition
– weight loss
Undigested food may persist in the stomach and solidify over time.
What Can You Do?
Gastroparesis lacks a cure, and plaintiffs are pursuing compensation to address the loss of their quality of life, past and future medical expenses, and other associated damages. If you believe you were injured by taking one of the diabetes or weight loss drugs described here, call the weight loss and diabetes drug lawyers at Thornton Law Firm at 888-491-9726 to discuss your legal rights. The consultation is free. All legal matters are subject to short, strictly enforced legal time limits. Call today to secure your legal rights. We may partner with other diabetes and weight loss drug lawyers on behalf of individuals harmed by side effects from these drugs.
